Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-24

Clinical Trial Update: Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma [Phase 2]

View source ↗

Summary

Circassia Limited announced the completion of its Grass-SPIRE Phase 2 trial in subjects with seasonal allergic rhinitis and asthma. The study status on Clinical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Grass-SPIRE

Snippet

Sponsor: Circassia Limited | Conditions: Seasonal Allergic Rhinitis, Asthma | Phase 2 | Status: COMPLETED